Status:
COMPLETED
Characteristics of Spiking in Ghent: a Multicentric Prospective Observational Study..
Lead Sponsor:
University Hospital, Ghent
Conditions:
Intoxication
Unintended Ingestion of Product
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to document the incidence and characteristics of spiking in the Ghent region, both anamnestically and by toxicological analysis. Spiking will be analyzed by immunoassay testing and hi...
Detailed Description
This study aims at objectivating and characterizing the patients with alleged spiking in the city of Ghent. Every patient who presents at one of the four (out of four) emergency departments of Ghent,...
Eligibility Criteria
Inclusion
- \>18 years
- Patient self-reports suspicion of spiking OR there is a suspicion of spiking by physician, police, paramedics or patient's companions
- willingness to provide urine and/or blood samples (depending on timing after event)
Exclusion
- Reporting more than 5 days after spiking
- Unable to reliably complete the questionnaire (can be after clinical observation/recovery).
- Not declaring proficiency in the language in which informed consent is offered (Dutch/English).
- Not agreeing to the informed consent.
- Do not consent to blood and urine collection and/or analysis.
- There is a suspicion of Drug Facilitated Sexual Assault (to be referred to Care Center Sexual Violence, ZSG, where parallel study is ongoing).
Key Trial Info
Start Date :
June 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT06207396
Start Date
June 1 2023
End Date
May 31 2025
Last Update
January 7 2026
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
AZ Maria Middelares
Ghent, Belgium, 9000
2
Spoedgevallendienst AZ Jan Palfijn
Ghent, Belgium, 9000
3
Spoedgevallendienst AZ St. Lucas
Ghent, Belgium, 9000
4
Spoedgevallendienst
Ghent, Belgium, 9000